Associate Professor Allison Jilbert
Hepatitis B virus is responsible for 1.2 million deaths a year, including 320,000 deaths due
to primary liver cancer. Associate Professor Allison Jilbert of the University of
Adelaide's School of Molecular and Biomedical Science has always wanted to know why.
How does Hep B alter liver cells? Why does it happen over time? Why is there a high risk of liver
cancer after a Hep B infection?
Allison and 350 million people worldwide are desperate for an answer. Armed with a long-held
curiosity about the way viruses mutate and hijack cells as a host, Allison and her team have Hep B
under the microscope.
“Our team is in a unique position to break through this baffling question. Close collaboration between the University of Adelaide, IMVS and the Royal
Adelaide Hospital gives our group the best chance for success.”
Already the talented team has patented a therapy for the treatment of this disease that often infects
the innocent.
Professor Jilbert believes team work will win out. “The University of Adelaide is at the forefront
of research in this vital field, and I believe collaboration is the key to our success.”
|